Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Convection-Enhanced Delivery of Glucocerebrosidase for the Treatment of Type 2 (Acute Neuronopathic) Gaucher Disease

NCT00244582 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT00244582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00244582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Convection-Enhanced Delivery of Glucocerebrosidase for the Treatment of Type 2 (Acute Neuronopathic) Gaucher Disease
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Observational
Overall status
Completed
Start date
October 22, 2005
Completion date
November 3, 2006
Enrollment
1
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 gaucher disease